Jonathan Hopper - Feb 18, 2022 Form 4 Insider Report for Vericel Corp (VCEL)

Role
Chief Medical Officer
Signature
/s/ Sean Flynn, as Attorney-in-Fact for Jonathan Hopper
Stock symbol
VCEL
Transactions as of
Feb 18, 2022
Transactions value $
-$86,552
Form type
4
Date filed
2/22/2022, 03:11 PM
Previous filing
Feb 15, 2022
Next filing
Mar 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VCEL Common Stock Options Exercise $0 +1.75K +3.9% $0.00 46.6K Feb 19, 2022 Direct F1, F2
transaction VCEL Common Stock Tax liability -$25.5K -730 -1.57% $34.90 45.9K Feb 19, 2022 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCEL Restricted Stock Unit Options Exercise -$61.1K -1.75K -25% $34.90 5.25K Feb 19, 2022 Common Stock 1.75K Direct F1, F4, F5
transaction VCEL Stock Option (right to buy) Award $0 +51.4K $0.00 51.4K Feb 18, 2022 Common Stock 51.4K $34.90 Direct F6
transaction VCEL Restricted Stock Unit Award $0 +9.3K $0.00 9.3K Feb 18, 2022 Common Stock 9.3K Direct F4, F5, F7
transaction VCEL Stock Option (right to buy) Award $0 +2.87K $0.00 2.87K Feb 18, 2022 Common Stock 2.87K $34.90 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 19, 2021. The remaining RSUs will vest in annual installments on February 19, 2023, February 19, 2024, and February 19, 2025, respectively.
F2 These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
F3 These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs.
F4 Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.
F5 No expiration date for this type of award.
F6 These options shall begin vesting on February 18, 2022 and shall continue to vest and become exercisable in equal quarterly installments over the course of the following four (4) year period.
F7 These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on February 18, 2023. The remaining RSUs will vest in annual installments on February 18, 2024, February 18, 2025, and February 18, 2026, respectively.